跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45 条关于
“Priovant”
全部
45
临床试验
9
药物
16
机构
5
资讯
15
去年
Priovant Eyes Broad Autoimmune Applications for Brepocitinib After Promising Phase II Results
5个月前
Priovant Launches Phase 2b/3 Trial for Brepocitinib in Lichen Planopilaris, Targeting Rare Scarring Hair Loss Disorder
去年
Brepocitinib Shows Promise in Non-Infectious Uveitis: Phase 3 Trial Initiated
上个月
Priovant Initiates Phase 3 BEACON+ Trial of Brepocitinib in Cutaneous Sarcoidosis Following Breakthrough Therapy Designation
7个月前
Priovant's Brepocitinib Shows Significant Efficacy in Rare Skin Disease Trial, Advancing to Phase 3
去年
Brepocitinib Achieves First-Ever Positive Phase 3 Results in Dermatomyositis, Setting New Treatment Standard
去年
Uveitis and Optic Neuritis Markets Set for Major Growth Through 2034 as New Therapies Advance
16年前
Urovant Sciences Launches GEMTESA® (vibegron) for Overactive Bladder Treatment in the U.S.
去年
Spirovant Sciences Doses First Patient in Cystic Fibrosis Gene Therapy Trial
2年前
Roivant Acquires Mosliciguat from Bayer for Pulmonary Hypertension Treatment
第 1 页,共 2 页
上一页
下一页